• Understand the appropriate diagnosis of psoriasis and psoriatic arthritis symptoms from cross-disciplinary perspectives to ensure early intervention.
• Employ appropriate strategies to diagnose and treat comorbidities associated with psoriatic disease.
• Outline the safety, efficacy & role of current & emerging treatments in addressing skin & joint symptoms for PsO and PsA, including complex psoriatic disease presentations, skin of color, AAD-NPF PsO treatments guidelines & ACR-NPF PsA treatment guidelines.
• Identify tools that different providers can use when screening for comorbid conditions related to PsO and PsA.
• Recognize and incorporate best practices (clinical pearls) regarding assessment, management and treatment options for psoriatic disease.
• Apply a patient-centric, collaborative care and appropriate shared management model for treatment of individuals living with psoriatic disease and how to establish an integrated practice setting or collaboration.

SPEAKERS

• Philip Mease, MD - Director, Rheumatology Research Swedish Medical Center/Providence St. Joseph Health; and Clinical Professor of Medicine at the University of Washington in Seattle
• Alexis Ogdie-Beatty, MD, MSCE - University of Pennsylvania
• Melissa Leeolou - Stanford University
• Pamela Weiss, MD, MSCE - Children's Hospital of Philadelphia
• Junko Takeshita, MD, PhD, MSCE, FAAD - University of Pennsylvania

ACCREDITATION

The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Psoriasis Foundation designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.